E-DRUG: The Cure of Chronic Hepatitis B <2>
-------------------------------------------
Dear E druggers,
Who's doing what? Who's paying who?
Before considering reading and discussing any book on drugs
I would appreciate independent reviews and guarantees that
there is no conflict of interest between authors, reviewers
and firms. The book in question is reported by one of the
authors and a drug company is apparently deeply involved in
its contents! Chronic hepatitis B is a severe condition and
commercial stakes are high.
Christophe Kopp
Editor of Prescrire International
La revue Prescrire
83 boulevard Voltaire 75011, Paris, France
Email: christophe.kopp@wanadoo.fr
--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.